InDel polymorphisms in quantitative posttransplant chi merism evaluation
Reduction of minimal residual disease to undetectable levels is the key criterion for efficiency of allogeneic hematopoietic stem cell transplantation (alloHSCT), along with engraftment of transplanted cells with complete replacement of recipient hematopoiesis, i.e., full posttransplant chimerism.Among different approaches, molecular genetic techni